Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
10/2002
10/17/2002US20020151483 C3b/C4b complement receptor-like molecules and uses thereof
10/17/2002US20020151478 Fusion protein comprising a latency associated peptide and a proteolytic cleavage site wherein the fusion protein is associated with a pharmaceutically active agent; gene therapy; genetic engineering; antiinflammatory agents
10/17/2002US20020151476 An isolated and purified antiviral protein or peptide from Nostoc ellipsosporum; viricides; coupled to an effector molecule; inhibits replication of a virus, e.g. a retrovirus, in particular a human immunodeficiency virus, HIV
10/17/2002US20020151463 Gene and polypeptide compositions in which expression of the agouti gene correlates with the development of insulin independent diabetes, hyperamylinemia, neoplasms and obesity
10/17/2002US20020151073 Transcription factor
10/17/2002US20020151072 Chimeric mutational vectors
10/17/2002US20020151071 Recovering mutant bacillus; obtain bacillus, transform with vector containing protein which deactivates hemolysin, recover bacillus with deactivated hemolysin activity, propagate
10/17/2002US20020151036 Process for producing cytidine diphosphate choline
10/17/2002US20020151035 Nucleotide sequences coding enzymatic polypeptide for use in generation of medicines
10/17/2002US20020151024 DNA encoding mammalian phosphodiesterases
10/17/2002US20020151023 GMP synthetase and gene coding for the same
10/17/2002US20020151022 Kinase capable of site-specific phosphorylation of IkappaBalpha
10/17/2002US20020151021 Stimulus-inducible protein kinase complex and methods of use therefor
10/17/2002US20020151018 Stearoyl-CoA desaturase gene promoter
10/17/2002US20020151015 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/17/2002US20020151011 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
10/17/2002US20020151009 Human polynucleotides, polypeptides, and antibodies
10/17/2002US20020151007 Nucleotide seauemces coding enzymatic polypeptide for use in the treatment, prevention of tumor
10/17/2002US20020151003 Method for the production of p-hydroxybenzoate in species of pseudomonas and agrobacterium
10/17/2002US20020151001 Nucleotide sequences coding for the ccpA1 gene
10/17/2002US20020150993 Nucleotide sequences coding polypeptide for use in the treament of apoptosis, inflammatory or autoimmune diseases
10/17/2002US20020150992 Nucleotide sequences coding polypeptide for us ein the treatment of immunological disorders
10/17/2002US20020150988 Nucleotide sequences coding polypeptide for use in the forensic analysis and diagnosis and treatment of genetic disorders
10/17/2002US20020150985 Polypeptide for use in the treatment of cancer
10/17/2002US20020150981 Methods for producing highly phosphorylated lysosomal hydrolases
10/17/2002US20020150977 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases
10/17/2002US20020150976 Nucleotide sequences coding polypeptide for use in the treatment of arthritis and bone disorders
10/17/2002US20020150974 Polypeptide for use in the diagnosis and treatment of osteoporosis and brain disorders
10/17/2002US20020150972 Nucleotide sequences coding polypeptide for use in the treatment of cancer
10/17/2002US20020150969 Generating peptidyl prolyl cis-trans isomerases; obtain cell, transform with vector containing isomerase, express vector, evaluate activity of enzyme
10/17/2002US20020150963 Map
10/17/2002US20020150962 Monitoring the sterilzation of preferential sample; obtain sample, expose to antiseptic compound, incubate with carrier, monitor sample for presence of microorganisms
10/17/2002US20020150951 Recovering preferential cells from sample; generate solid support, incubate with cell sample, elute and recover cells
10/17/2002US20020150946 Mammalian tolloid-like gene and protein
10/17/2002US20020150931 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of preferential genetic disorder
10/17/2002US20020150902 Polymorphic loci that differentiate escherichia coli 0157:H7 from other strains
10/17/2002US20020150888 Methods of screening for modulators of HIV infection
10/17/2002US20020150881 Recovering nucleotide sequences coding preferential protein; obtain phage coding preferential protein, express protein, separate phage displaying binding domain, recover phage displaying chimeric binding protein on surface
10/17/2002US20020150593 Mycoplasma vaccine
10/17/2002US20020150591 Amplification nucleic acids
10/17/2002US20020150587 Immunological polypeptides; vaccine against gramnegative bacteria
10/17/2002US20020150577 Transforming growth factor; transgenic animal; increas ratios of muscle mass
10/17/2002US20020150559 Binding of human antigens
10/17/2002DE10201458A1 New proteins involved in isoprenoid biosynthesis, useful in screening for inhibitors, also new intermediates, potential therapeutic agents, nucleic acids and antibodies
10/17/2002DE10162387A1 Für das rpoB-Gen kodierende Nukleotidsequenzen For the rpoB gene coding nucleotide sequences
10/17/2002DE10117816A1 Improved production of L-amino acids in coryneform bacteria, useful particularly in animal nutrition, by reducing activity of malate-quinone oxidoreductase
10/17/2002DE10116788A1 Nichtpathogener bakterieller Poringen-Rezipientenstamm eines Mycolsäure-haltigen Bakteriums, Verfahren zu dessen Herstellung und dessen Verwendung Nonpathogenic bacterial porin-recipient strain of mycolic acid-containing bacteria, a process for its preparation and its use
10/17/2002DE10116519A1 Preparation of pantothenic acid, useful especially as animal feed supplement, comprises fermenting coryneform bacteria that overexpress the glyA gene
10/17/2002CA2794446A1 Uncoupled productive and catabolic host cell pathways
10/17/2002CA2699611A1 Desaturase genes and uses thereof
10/17/2002CA2698579A1 Desaturase genes and uses thereof
10/17/2002CA2443813A1 Method for identification of proteins from intracellular bacteria
10/17/2002CA2443685A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/17/2002CA2443377A1 D-hydantoinase from ochrobactrum anthropi
10/17/2002CA2443372A1 Immunotherapeutic combinations for the treatment of tumors that over-express gangliosides
10/17/2002CA2443341A1 Human gene critical to fertility
10/17/2002CA2443334A1 Protein modification and maintenance molecules
10/17/2002CA2443323A1 Nucleic acid vaccines for prevention of flavivirus infection
10/17/2002CA2443303A1 Method for preparing and selecting antibodies
10/17/2002CA2443275A1 Improved gene expression
10/17/2002CA2443145A1 Uncoupled productive and catabolic host cell pathways
10/17/2002CA2442935A1 Alcohol oxidase 1 regulatory nucleotide sequences for heterologous gene expression in yeast
10/17/2002CA2442839A1 Production and use of novel peptide-based agents for use with bi-specific antibodies
10/17/2002CA2442817A1 Implantation serine proteinases
10/17/2002CA2442739A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/17/2002CA2442386A1 Epitope sequences
10/17/2002CA2441633A1 Fragment of l. lactis plasmid conferring antiphage activity and uses thereof
10/17/2002CA2439342A1 Oryza sativa nuclear cap binding protein 80
10/17/2002CA2435528A1 Novel polypeptides and nucleic acids encoded thereby
10/17/2002CA2434456A1 Yeast genes that affect viral replication
10/17/2002CA2429376A1 Mitogenic oxygenase regulators
10/16/2002EP1249498A2 Alzheimer's disease secretase, APP substrates therefor, and uses therefor
10/16/2002EP1249494A1 Process for the biological production of l-pipecolic acid
10/16/2002EP1249490A2 In vitro activation of cytotoxic T cells
10/16/2002EP1249456A1 Novel peptide and screening method by using the same
10/16/2002EP1248849A1 Obg3 globular head and uses thereof for decreasing body mass
10/16/2002EP1248847A1 Irak-4: compositions and methods of use
10/16/2002EP1248843A2 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses
10/16/2002EP1248841A2 Genes differentially expressed in breast cancer
10/16/2002EP1248803A2 Nogo receptor-mediated blockade of axonal growth
10/16/2002EP1248801A1 Human polynucleotides, polypeptides, and antibodies
10/16/2002EP1248754A1 Biological addition to organic-mineral fertilizers
10/16/2002EP1248611A1 Inhibition of two-component signal transduction systems
10/16/2002EP1248536A2 Porphyrin containing lactic acid bacterial cells and use thereof
10/16/2002EP1248516A2 38 human secreted proteins
10/16/2002EP1030566B1 Use of liquid carbohydrate fermentation product in foods
10/16/2002EP0973794B1 Netrin receptors
10/16/2002EP0866875B1 Method for producing glycogen or a glycogen-enriched extract from yeast cells, and cosmetic composition containing same
10/16/2002EP0774001B1 Production of tissue factor pathway inhibitor
10/16/2002EP0670847B1 Subtilin variant of enhanced stability and activity
10/16/2002EP0639225B1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
10/16/2002CN1375008A Recombinant hosts suitable for simultaneous saccharification and fermentation
10/16/2002CN1375006A Novel compound
10/16/2002CN1374970A Signal sequence for the productino of leu-hirudine via secretion by E coli in a culture medium
10/16/2002CN1374404A Expression box and plasmid for constitutive gene strong expression
10/16/2002CN1374402A Once Aspergillus niger fermentation process of obtaining complex enzyme of several kinds of enzyme and with high enzyme activity
10/16/2002CN1374400A Process for producing L-cysteine bacterium and L-cysteine
10/16/2002CN1374399A Waxy bacillus and its prepn
10/16/2002CN1374398A Prepn and use of enzyme prepn for use in hemp degluing industrial process
10/16/2002CN1374384A Nutritious health beer